Last updated on 7 Apr 2022
Owner Info
Ligand Pharmaceuticals Incorporated
5980 Horton Street, Suite 405
Emeryville CA 94608, UNITED STATES OF AMERICA
Serial Number
2022262 filed on 4 Jun 2019
Correspondent
Lisa M. Martens Sheppard Mullin Richter & Hampton LLP
12275 El Camino Real, Suite 200,
San Diego CA 92130-2006,
UNITED STATES OF AMERICA
2022262
4 Jun 2019
4 Jun 2029
WORD
7 Dec 2018
US
Status Date | Action Taken |
---|---|
7th Apr 2022 | Amendment to Amend Owner Requested |
3rd Dec 2020 | Amendment to Amend Owner Requested |
14th Jan 2020 | International Registration in Australia Protected correspondence sent |
13th Jan 2020 | IP Right Registration Published |
13th Jan 2020 | Status change to Registered/Protected |
5th Nov 2019 | Application Accepted correspondence sent |
4th Nov 2019 | IP Right Acceptance Published |
4th Nov 2019 | IP Right has been Examined |
4th Nov 2019 | Status change to Accepted |
12th Jul 2019 | Examination expedited |